Company profile for RARE DIS THERAP

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The story of Rare Disease Therapeutics, Inc., is the story of hope vs. reality. We specialize in filling very specific and special medical needs of a small population of adults and children seeking life-preserving therapies for rare diseases. Many of these diseases are not immediately recognizable to even the most astute physicians; therefore, the role of Rare Disease Therapeutics, Inc., must include creating awareness of such...
The story of Rare Disease Therapeutics, Inc., is the story of hope vs. reality. We specialize in filling very specific and special medical needs of a small population of adults and children seeking life-preserving therapies for rare diseases. Many of these diseases are not immediately recognizable to even the most astute physicians; therefore, the role of Rare Disease Therapeutics, Inc., must include creating awareness of such diseases and their diagnosis. Unfortunately, the reality is that all too few companies are willing to invest in low volume, low return research programs. Thus the needs of the few are lost to corporate profit/loss statements. Rare Disease Therapeutics, Inc., on the other hand, is a company built on the hope and premise of providing options where there are no options, and providing therapies where there are no therapies, through creative strategic alliances, as well as unique relationships with the government, research institutions, physicians, scientist, and manufacturers. Rare Disease Therapeutics, Inc., is a well established company founded in 1991 as Orphan Pharmaceuticals, U.S.A., Inc., strategically located in Nashville, Tennessee. The company changed its name to Rare Disease Therapeutics, Inc., in March 2001 to better describe its mission. Rare Disease Therapeutics, Inc., has a solid track record with multiple licensing agreements, a comprehensive global patient advocacy network, and significant success in drug development and approval. The company’s major clinical expertise and licensing focus have been in rare diseases in the following therapeutic areas: • Oncology • Genetic disorders • Hematology • Metabolic diseases • Poison control • Hepatic diseases In addition to the above cited therapeutic areas, Rare Disease Therapeutics, Inc., is also seeking current orphan products or low volume mature products that would be considered as orphans if these products were launched today.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Rare Disease Therapeutics, Inc. 2550 Meridian Blvd, Suite 150 Franklin, Tennes...
Telephone
Telephone
615-399-0700
Client Website
Website
--
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty